Beta
35380

Genotoxic Effects of the Anti-Cancer Drug Doxorubicin (Dxr) in the Bone Marrow Cells of Swiss Albino Mice (Mus musculus)

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

-

Abstract

The antineoplastic chemotherapeutic agent doxorubicin (DXR) is probably the most utilized drug for treating many human cancers. In the current study we aimed to evaluate the genotoxic effects of doxorubicin Swiss mice bone marrow cells using the toxicological endpoints chromosomal aberrations, mitotic index and micronuclei formation. Twelve male animals, aged 6-8 weeks and weighing 24±2g were divided into four groups. One group served as control was intraperitoneally injected only with distilled water. The three remaining groups were injected intraperitoneally with single doses of doxorubicin (0.2, 0.4 and 0.8 mg/g body weight) for two consecutive days. 24 hours later, animals were anaesthetized and killed by cervical dislocation. Colchicine (0.05 %) was injected to animals 90 minutes before sacrifice. After sacrificing the animals, both femurs were dissected out and the bone marrow cells obtained. All treatments with doxorubicin caused an increased significance in the incidence of chromosomal aberrations (CA) and micronuclei formation in polychromatic erythrocytes (PCEs) cells. Meanwhile, there was a gradual repression in the mitotic index (MI) percentages of the treated groups compared to that of the control.  Different types of chromosomal aberrations (structural and numerical) were induced as a result of doxorubicin treatments. These includes: gaps, breaks, fragments, rings, centric fusions (CF) and polyploidy. The mean percentages of total chromosomal aberrations increased from 3.33 ± 0.28 in the control group to 12.67 ± 2.42, 29.00 ± 4.27 and 38.67 ± 2.82 for doses 0.2, 0.4 and 0.8 mg/kg B.W. respectively. The numbers of micronucleated PCEs observed in mice cells treated with doxorubicin were increased from 4.67±0.48 for the control group to 7.00±1.02, 10.67±2.10 and 17.67 for the three doses respectively. Meanwhile, the PCE / (PCE+NCE) ratio calculated in treated animals were 0.85 ± 0.02, 0.63 ± 0.08 and 0.54 ± 0.10 compared to 0.94 ± 0.12 for the control. Our results indicated that doxorubicin has genotoxic as well as cytotoxic effects in mice bone marrow cells.

DOI

10.21608/jacb.2018.35380

Keywords

Doxorubicin, mice bone marrow, chromosomal aberrations, Mitotic index, Micronuclei

Authors

First Name

N.

Last Name

Mohamed

MiddleName

-

Affiliation

Genetics Dept., Faculty of Agriculture, Assiut Univ., Egypt.

Email

-

City

-

Orcid

-

First Name

Mervat

Last Name

Hashad

MiddleName

-

Affiliation

Genetics Dept., Faculty of Agriculture, Assiut Univ., Egypt.

Email

-

City

-

Orcid

-

First Name

K.

Last Name

Amein

MiddleName

-

Affiliation

Genetics Dept., Faculty of Agriculture, Assiut Univ., Egypt.

Email

-

City

-

Orcid

-

First Name

Ebtsam

Last Name

Hafez

MiddleName

-

Affiliation

Genetics Dept., Faculty of Agriculture, Assiut Univ., Egypt.

Email

-

City

-

Orcid

-

Volume

9

Article Issue

9

Related Issue

5837

Issue Date

2018-09-01

Receive Date

2018-09-05

Publish Date

2018-09-01

Page Start

211

Page End

215

Print ISSN

2090-3626

Online ISSN

2090-3707

Link

https://jacb.journals.ekb.eg/article_35380.html

Detail API

https://jacb.journals.ekb.eg/service?article_code=35380

Order

3

Type

Original Article

Type Code

883

Publication Type

Journal

Publication Title

Journal of Agricultural Chemistry and Biotechnology

Publication Link

https://jacb.journals.ekb.eg/

MainTitle

Genotoxic Effects of the Anti-Cancer Drug Doxorubicin (Dxr) in the Bone Marrow Cells of Swiss Albino Mice (Mus musculus)

Details

Type

Article

Created At

22 Jan 2023